"progression free survival" trang 2 - tải miễn phí từ tailieunhanh
Nomograms predict long-term survival for patients with periampullary adenocarcinoma after pancreatoduodenectomy

Nomograms predict long-term survival for patients with periampullary adenocarcinoma after pancreatoduodenectomy
11    43    1
Impact of diabetes mellitus on epithelial ovarian cancer survival

Impact of diabetes mellitus on epithelial ovarian cancer survival
6    37    1
Baseline serum tumor markers predict the survival of patients with advanced non-small cell lung cancer receiving frst-line immunotherapy: A multicenter retrospective study

Baseline serum tumor markers predict the survival of patients with advanced non-small cell lung cancer receiving frst-line immunotherapy: A multicenter retrospective study
21    1    1
Improved clinical outcomes in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus atezolizumab and bevacizumab: A bicentric retrospective study

Improved clinical outcomes in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus atezolizumab and bevacizumab: A bicentric retrospective study
8    1    1
Higher number of multidisciplinary tumor board meetings per case leads to improved clinical outcome

Higher number of multidisciplinary tumor board meetings per case leads to improved clinical outcome
9    107    0
Cisplatin-based chemotherapy with or without bevacizumab for Chinese postmenopausal women with advanced cervical cancer: A retrospective observational study

Cisplatin-based chemotherapy with or without bevacizumab for Chinese postmenopausal women with advanced cervical cancer: A retrospective observational study
8    70    0
Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: A retrospective analysis

Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: A retrospective analysis
13    81    0
A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen

A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen
8    40    1
Prognostic value of CC-chemokine receptor seven expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor

Prognostic value of CC-chemokine receptor seven expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor
10    38    1
Chemotherapy for intracranial ependymoma in adults

Chemotherapy for intracranial ependymoma in adults
12    31    1
S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: Updated results from a phase 3 trial

S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: Updated results from a phase 3 trial
7    50    2
PERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: A translational subgroup analysis from AIO-PK0104

PERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: A translational subgroup analysis from AIO-PK0104
10    45    1
Cetuximab versus bevacizumab following prior FOLFOXIRI and bevacizumab in postmenopausal women with advanced KRAS and BRAF wild-type colorectal cancer: A retrospective study

Cetuximab versus bevacizumab following prior FOLFOXIRI and bevacizumab in postmenopausal women with advanced KRAS and BRAF wild-type colorectal cancer: A retrospective study
8    31    1
Long-term progression-free survival in an advanced lung adenocarcinoma patient harboring EZR-ROS1 rearrangement: A case report

Long-term progression-free survival in an advanced lung adenocarcinoma patient harboring EZR-ROS1 rearrangement: A case report
5    51    1
RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin

RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin
11    54    1
Chemotherapy versus chemoradiotherapy for FIGO stages IB1 and IIA1 cervical squamous cancer patients with lymphovascular space invasion: A retrospective study

Chemotherapy versus chemoradiotherapy for FIGO stages IB1 and IIA1 cervical squamous cancer patients with lymphovascular space invasion: A retrospective study
8    18    1
Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child–Pugh B liver function at study week 8: A retrospective analysis of the CELESTIAL randomised controlled trial

Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child–Pugh B liver function at study week 8: A retrospective analysis of the CELESTIAL randomised controlled trial
10    14    1
Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: A multicenter retrospective study

Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: A multicenter retrospective study
11    2    1
FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: A retrospective observational study

FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: A retrospective observational study
8    4    1
Recurrence and survival of patients with stage III endometrial cancer after radical surgery followed by adjuvant chemoor chemoradiotherapy: A systematic review and meta-analysis

Recurrence and survival of patients with stage III endometrial cancer after radical surgery followed by adjuvant chemoor chemoradiotherapy: A systematic review and meta-analysis
12    7    1